Acceptability of Extended-Release Naltrexone by Heroin-Dependent Patients and Addiction Treatment Providers in the Netherlands
Zaaijer, E.R.,
Goudriaan, A.E., Koeter, M.W.J.,
Booij, J. &
Van den Brink, W.Verschenen in Substance Use & Misuse, 51 (14), 1905-1911 (2016)
Effect of extended-release naltrexone on striatal dopamine transporter availability, depression and anhedonia in heroin-dependent patients
Zaaijer, E.R., van Dijk, L., de Bruin, K.,
Goudriaan, A.E., Lammers, L.A., Koeter, M.W.J.,
Van den Brink, W. &
Booij, J.Verschenen in Psychopharmacology, 232 (14), 2597-2607 (2015)
Subchronic administration of short-acting naltrexone has no effect on striatal dopamine transporter availability, food intake or body weight gain in rats
Zaaijer, E.R., de Bruin, K., la Fleur, S.E.,
Goudriaan, A.E.,
Van den Brink, W. &
Booij, J.Verschenen in Journal of Psychopharmacology, 29 (3), 344-348 (2015)
Personality as a risk factor for illicit opioid use and a protective factor for illicit opioid dependence
Zaaijer, E.R., Bruijel, J., Blanken, P.,
Hendriks, V., Koeter, M.W.J., Kreek, M.J.,
Booij, J.,
Goudriaan, A.E., van Ree, J.M. &
Van den Brink, W.Verschenen in Drug and Alcohol Dependence, 145, 101-105 (2014)